| Name | Title | Contact Details |
|---|
Holistic training, health and retirement benefits for Washington states professional home caregivers.
The American Journal of Pharmacy Benefits is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In January 2014, Jordan Hospital joined the Beth Israel Deaconess Medical Center family of hospitals and become Beth Israel Deaconess Hospital-Plymouth. In 1899, a group of leading citizens from Plymouth saw a need to build a hospital to serve residents and pursued the idea of "a hospital on the hill". They approached retail tycon, philanthropist, and summer resident Eben Jordan, of the Jordan Marsh Company, and he donated $20,000 to build was was to become Jordan Hospital. In December 1903, Jordan Hospital opened its doors to the first patients and has remained a community hospital ever since. In 2014, Jordan Hospital become Beth Israel Deaconess Hospital-Plymouth and remains a private, not-for-profit hospital. We treat all patients, regardless of ability to pay. We proudly serve the communities of Bourne, Carver, Duxbury, Halifax, Kingston, Lakeville, Pembroke, Plympton, Plymouth, Marshfield, Middleboro, Sandwich and Wareham, as well as numerous visitors to our historic area. Beth Israel Deaconess-Plymouth is an affiliate of Beth Israel Deaconess Medical Center in Boston.
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.
Century Care Ctr is a Century, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.